Want to join the conversation?
Tien-tsin Huang of JPMorgan asks about free cash flow outlook for 3Q16 & 4Q16. CFO James Woodall replied that $FIS has been very focused in trying to improve collections, drop costs out and generate free cash flow to make sure it can pay the debt down. He added that the company anticipates continuing to see it outpace adjusted net earnings in 2016.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?